Evidence map›Paper›PMID 24316837›Full record

ArticleActa crystallographica. Section F, Structural biology and crystallization communications2013

Crystallization and sulfur SAD phasing of AggA, the major subunit of aggregative adherence fimbriae type I from the Escherichia coli strain that caused an outbreak of haemolytic-uraemic syndrome in Germany.

Natalia Pakharukova, Minna Tuittila, Anton Zavialov

Abstract read
In one paragraph

Article in Acta crystallographica. Section F, Structural biology and crystallization communications, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Natalia PakharukovaDepartment of Chemistry, University of Turku, Joint Biotechnology Laboratory, BioCity, Tykistökatu 6A, 20520 Turku, Finland.
Minna Tuittila
Anton Zavialov

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The outbreak of Shiga toxin-producing Escherichia coli O104:H4 infection in Germany in 2011 was associated with significant mortality and morbidity owing to the progressive development of haemolytic-uraemic syndrome. The outbreak strain emerged recently as a result of horizontal transfer events leading to the acquisition of a number of virulence factors. Among them, aggregative adherence fimbriae type I (AAF/I) are considered to be particularly important since they are involved in the initial attachment of bacteria to the intestinal mucosa. Here, the crystallization and preliminary X-ray diffraction analysis of the major subunit of AAF/I, AggA, are reported. Crystallization of recombinant donor-strand complemented AggA was performed by the vapour-diffusion method. The crystals diffracted to 1.55 Å resolution and belonged to the orthorhombic space group C222(1), with unit-cell parameters a = 77.83, b = 80.17, c = 91.42 Å. Despite a low sulfur content of the protein [0.57%(w/w)], sufficiently accurate initial phases were derived from a sulfur SAD experiment.

Indexed as

Amino Acid SequenceBacterial AdhesionCrystallizationCrystallography, X-RayDisease OutbreaksEscherichia coli ProteinsFimbriae ProteinsGene ExpressionGermanyHemolytic-Uremic SyndromeHumansMolecular Sequence DataProtein SubunitsRecombinant ProteinsShiga-Toxigenic Escherichia coliSulfurAggA protein, E coliEscherichia coli ProteinsFimbriae ProteinsProtein SubunitsRecombinant ProteinsSulfuraggregative adherence fimbriaechaperone/usher pathwayH4Shiga toxin-producing Escherichia coli O104sulfur single anomalous diffraction

Identifiers

PMID24316837
PMCPMC3855727

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.